Literature DB >> 20382893

c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes.

Pili Zhang1, Mallikarjurna R Metukuri, Sharell M Bindom, Edward V Prochownik, Robert M O'Doherty, Donald K Scott.   

Abstract

Glucose regulates programs of gene expression that orchestrate changes in cellular phenotype in several metabolically active tissues. Carbohydrate response element-binding protein (ChREBP) and its binding partner, Mlx, mediate glucose-regulated gene expression by binding to carbohydrate response elements on target genes, such as the prototypical glucose-responsive gene, liver-type pyruvate kinase (Pklr). c-Myc is also required for the glucose response of the Pklr gene, although the relationship between c-Myc and ChREBP has not been defined. Here we describe the molecular events of the glucose-mediated activation of Pklr and determine the effects of decreasing the activity or abundance of c-Myc on this process. Time-course chromatin immunoprecipitation revealed a set of transcription factors [hepatocyte nuclear factor (HNF)1alpha, HNF4alpha, and RNA polymerase II (Pol II)] constitutively resident on the Pklr promoter, with a relative enrichment of acetylated histones 3 and 4 in the same region of the gene. Glucose did not affect HNF1alpha binding or the acetylation of histones H3 or H4. By contrast, glucose promoted the recruitment of ChREBP and c-Myc and increased the occupancy of HNF4alpha and RNA Pol II, which were coincident with the glucose-mediated increase in transcription as determined by a nuclear run-on assay. Depletion of c-Myc activity using a small molecule inhibitor (10058-F4/1RH) abolished the glucose-mediated recruitment of HNF4alpha, ChREBP, and RNA Pol II, without affecting basal gene expression, histone acetylation, and HNF1alpha or basal HNF4alpha occupancy. The activation and recruitment of ChREBP to several glucose-responsive genes were blocked by 1RH, indicating a general necessity for c-Myc in this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382893      PMCID: PMC2875801          DOI: 10.1210/me.2009-0437

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  57 in total

Review 1.  Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism.

Authors:  James J Collier; Donald K Scott
Journal:  Mol Endocrinol       Date:  2003-12-23

2.  Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins.

Authors:  E Soutoglou; G Papafotiou; N Katrakili; I Talianidis
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

3.  The pyruvate kinase gene as a model for studies of glucose-dependent regulation of gene expression in the endocrine pancreatic beta-cell type.

Authors:  S Marie; M J Diaz-Guerra; L Miquerol; A Kahn; P B Iynedjian
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

4.  Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver.

Authors:  E Riu; F Bosch; A Valera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

Authors:  K Yamagata; N Oda; P J Kaisaki; S Menzel; H Furuta; M Vaxillaire; L Southam; R D Cox; G M Lathrop; V V Boriraj; X Chen; N J Cox; Y Oda; H Yano; M M Le Beau; S Yamada; H Nishigori; J Takeda; S S Fajans; A T Hattersley; N Iwasaki; T Hansen; O Pedersen; K S Polonsky; G I Bell
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

6.  Functional synergism in the carbohydrate-induced activation of liver-type pyruvate kinase gene expression.

Authors:  Z Liu; H C Towle
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

7.  Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative.

Authors:  K Yamagata; Q Yang; K Yamamoto; H Iwahashi; J Miyagawa; K Okita; I Yoshiuchi; J Miyazaki; T Noguchi; H Nakajima; M Namba; T Hanafusa; Y Matsuzawa
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

8.  Binding of myc proteins to canonical and noncanonical DNA sequences.

Authors:  T K Blackwell; J Huang; A Ma; L Kretzner; F W Alt; R N Eisenman; H Weintraub
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

Review 9.  Nutrient and hormonal regulation of pyruvate kinase gene expression.

Authors:  K Yamada; T Noguchi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

10.  Carbohydrate regulation of the rat L-type pyruvate kinase gene requires two nuclear factors: LF-A1 and a member of the c-myc family.

Authors:  Z Liu; K S Thompson; H C Towle
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  29 in total

1.  ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.

Authors:  Michael Boergesen; Lars la Cour Poulsen; Søren Fisker Schmidt; Francesca Frigerio; Pierre Maechler; Susanne Mandrup
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

2.  A lack of ChREBP inhibits mitochondrial cristae formation in brown adipose tissue.

Authors:  Haruhiko Sakiyama; Lan Li; Sachi Kuwahara-Otani; Tsutomu Nakagawa; Hironobu Eguchi; Daisaku Yoshihara; Masakazu Shinohara; Noriko Fujiwara; Keiichiro Suzuki
Journal:  Mol Cell Biochem       Date:  2021-05-21       Impact factor: 3.396

Review 3.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

Review 4.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

5.  Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.

Authors:  Patrick A Carroll; Daniel Diolaiti; Lisa McFerrin; Haiwei Gu; Danijel Djukovic; Jianhai Du; Pei Feng Cheng; Sarah Anderson; Michelle Ulrich; James B Hurley; Daniel Raftery; Donald E Ayer; Robert N Eisenman
Journal:  Cancer Cell       Date:  2015-01-29       Impact factor: 31.743

6.  cMyc is a principal upstream driver of beta-cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta-cell replication.

Authors:  Esra Karslioglu; Jeffrey W Kleinberger; Fatimah G Salim; Amy E Cox; Karen K Takane; Donald K Scott; Andrew F Stewart
Journal:  Mol Endocrinol       Date:  2011-09-01

7.  The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

Authors:  Arvin M Gouw; Katherine Margulis; Natalie S Liu; Sudha J Raman; Anthony Mancuso; Georgia G Toal; Ling Tong; Adriane Mosley; Annie L Hsieh; Delaney K Sullivan; Zachary E Stine; Brian J Altman; Almut Schulze; Chi V Dang; Richard N Zare; Dean W Felsher
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

8.  Myc Is Required for Adaptive β-Cell Replication in Young Mice but Is Not Sufficient in One-Year-Old Mice Fed With a High-Fat Diet.

Authors:  Carolina Rosselot; Anil Kumar; Jayalakshmi Lakshmipathi; Pili Zhang; Geming Lu; Liora S Katz; Edward V Prochownik; Andrew F Stewart; Luca Lambertini; Donald K Scott; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2019-07-10       Impact factor: 9.461

9.  Immune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma development.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

10.  Glucose regulates the intrinsic inflammatory response of the heart to surgically induced hypothermic ischemic arrest and reperfusion.

Authors:  Ahmed S Bux; Merry L Lindsey; Hernan G Vasquez; Heinrich Taegtmeyer; Romain Harmancey
Journal:  Physiol Genomics       Date:  2016-12-09       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.